
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Promises of microbiome-based therapies
Jasmohan S. Bajaj, Siew C. Ng, Bernd Schnabl
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1379-1391
Open Access | Times Cited: 71
Jasmohan S. Bajaj, Siew C. Ng, Bernd Schnabl
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1379-1391
Open Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Frank Tacke, Tobias Puengel, Rohit Loomba, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 552-566
Closed Access | Times Cited: 143
Frank Tacke, Tobias Puengel, Rohit Loomba, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 552-566
Closed Access | Times Cited: 143
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 15
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 15
Why Do So Many Nonalcoholic Steatohepatitis Trials Fail?
Vlad Ratziu, Scott L. Friedman
Gastroenterology (2020) Vol. 165, Iss. 1, pp. 5-10
Closed Access | Times Cited: 70
Vlad Ratziu, Scott L. Friedman
Gastroenterology (2020) Vol. 165, Iss. 1, pp. 5-10
Closed Access | Times Cited: 70
Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions
Jayashi Rajapakse, Saroj Khatiwada, Anna Camille Akon, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 31
Jayashi Rajapakse, Saroj Khatiwada, Anna Camille Akon, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 31
Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
M.J.M. de Koning, Hilde Herrema, Max Nieuwdorp, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
M.J.M. de Koning, Hilde Herrema, Max Nieuwdorp, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Health and Disease: Akkermansia muciniphila , the Shining Star of the Gut Flora
Chen Xue, Ganglei Li, Xinyu Gu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 21
Chen Xue, Ganglei Li, Xinyu Gu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 21
Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation
Bozhong Shi, Haoyu Li, Xiaomin He
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Bozhong Shi, Haoyu Li, Xiaomin He
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001–2023)
Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 7
Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 7
Mucoadhesive probiotic-based oral microcarriers with prolonged intestinal retention for inflammatory bowel disease therapy
Kairuo Wang, Qian Chen, Li Ding, et al.
Nano Today (2023) Vol. 50, pp. 101876-101876
Closed Access | Times Cited: 20
Kairuo Wang, Qian Chen, Li Ding, et al.
Nano Today (2023) Vol. 50, pp. 101876-101876
Closed Access | Times Cited: 20
Phage therapy: Targeting intestinal bacterial microbiota for the treatment of liver diseases
Jumpei Fujiki, Bernd Schnabl
JHEP Reports (2023) Vol. 5, Iss. 12, pp. 100909-100909
Open Access | Times Cited: 16
Jumpei Fujiki, Bernd Schnabl
JHEP Reports (2023) Vol. 5, Iss. 12, pp. 100909-100909
Open Access | Times Cited: 16
Intestinal mucosal mitochondrial oxidative phosphorylation worsens with cirrhosis progression and is ameliorated with FMT
Jing Zeng, Derrick Zhao, Grayson W. Way, et al.
JCI Insight (2025)
Open Access
Jing Zeng, Derrick Zhao, Grayson W. Way, et al.
JCI Insight (2025)
Open Access
Exploring Extracellular Vesicles: A Novel Approach in Nonalcoholic Fatty Liver Disease
Ana Isabel Vigil Medina, Mengdie Shi, Yanyan Wang, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Ana Isabel Vigil Medina, Mengdie Shi, Yanyan Wang, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Lactobacillus vaginalis alleviates DSS induced colitis by regulating the gut microbiota and increasing the production of 3-indoleacrylic acid
Zhuoya Wang, Liu Tian, Li Liu, et al.
Pharmacological Research (2025) Vol. 213, pp. 107663-107663
Open Access
Zhuoya Wang, Liu Tian, Li Liu, et al.
Pharmacological Research (2025) Vol. 213, pp. 107663-107663
Open Access
Causal relationship between gut microbiota, lipids, and neuropsychiatric disorders: A Mendelian randomization mediation study
Nan Zhang, Xiaoyu Dong
Journal of Affective Disorders (2025)
Closed Access
Nan Zhang, Xiaoyu Dong
Journal of Affective Disorders (2025)
Closed Access
Gut microbiota‐derived tryptophan metabolites improve total parenteral nutrition‐associated infections by regulating Group 3 innate lymphoid cells
Longchang Huang, Peng Wang, Shuai Liu, et al.
iMeta (2025)
Open Access
Longchang Huang, Peng Wang, Shuai Liu, et al.
iMeta (2025)
Open Access
Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Wesam Bahitham, S. Al-Ghamdi, Ibrahim Omer, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 550-550
Open Access | Times Cited: 4
Wesam Bahitham, S. Al-Ghamdi, Ibrahim Omer, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 550-550
Open Access | Times Cited: 4
Impact of Lactobacillaceae supplementation on the multi-organ axis during MASLD
André A. Santos, Raquel Duarte, Madalena Duarte, et al.
Life Sciences (2024) Vol. 354, pp. 122948-122948
Open Access | Times Cited: 4
André A. Santos, Raquel Duarte, Madalena Duarte, et al.
Life Sciences (2024) Vol. 354, pp. 122948-122948
Open Access | Times Cited: 4
Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?
Nicolas Lanthier, Nathalie M. Delzenne
Cells (2022) Vol. 11, Iss. 17, pp. 2718-2718
Open Access | Times Cited: 20
Nicolas Lanthier, Nathalie M. Delzenne
Cells (2022) Vol. 11, Iss. 17, pp. 2718-2718
Open Access | Times Cited: 20
Research Priorities for Precision Medicine in NAFLD
Paula Iruzubieta, Ramón Bataller, M. Arias, et al.
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 535-551
Open Access | Times Cited: 11
Paula Iruzubieta, Ramón Bataller, M. Arias, et al.
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 535-551
Open Access | Times Cited: 11
Potential therapies for acute‐on‐chronic liver failure
Maura A. Morrison, Florent Artru, Francesca M. Trovato, et al.
Liver International (2023)
Open Access | Times Cited: 10
Maura A. Morrison, Florent Artru, Francesca M. Trovato, et al.
Liver International (2023)
Open Access | Times Cited: 10
Alcohol-associated liver disease: Emerging therapeutic strategies
Benjamin H. Mullish, Mark Thursz
Hepatology (2024) Vol. 80, Iss. 6, pp. 1372-1389
Closed Access | Times Cited: 3
Benjamin H. Mullish, Mark Thursz
Hepatology (2024) Vol. 80, Iss. 6, pp. 1372-1389
Closed Access | Times Cited: 3
The Role of Akkermansia muciniphila on Improving Gut and Metabolic Health Modulation: A Meta-Analysis of Preclinical Mouse Model Studies
Leila Khalili, Gwoncheol Park, Ravinder Nagpal, et al.
Microorganisms (2024) Vol. 12, Iss. 8, pp. 1627-1627
Open Access | Times Cited: 3
Leila Khalili, Gwoncheol Park, Ravinder Nagpal, et al.
Microorganisms (2024) Vol. 12, Iss. 8, pp. 1627-1627
Open Access | Times Cited: 3
Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota
Jang Han Jung, Sung Eun Kim, Ki Tae Suk, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 17
Jang Han Jung, Sung Eun Kim, Ki Tae Suk, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 17
Healthy microbiome – a mere idea or a sound concept?
Lucie Najmanová, Petra Vídeňská, Monika Cahová
Physiological Research (2022) Vol. 71, Iss. 6, pp. 719-738
Open Access | Times Cited: 16
Lucie Najmanová, Petra Vídeňská, Monika Cahová
Physiological Research (2022) Vol. 71, Iss. 6, pp. 719-738
Open Access | Times Cited: 16